Scholarlink

<p>Urate oxidase (uricase; EC 1.7.3.3) catalyzes the oxidation of uric acid to allantoin, a highly soluble metabolite that is readily excreted. Lack of functional urate oxidase in human’s leads to hyperuricemia, which is associated with gout, tumor lysis syndrome and renal complications. The present study reports statistical optimization, purification, and comprehensive characterization of a novel extracellular urate oxidase secreted by <i>Arthrobacter creatinolyticus</i> SA1. Plackett–Burman Design screening followed by Central Composite Design identified inoculum volume, initial pH, peptone, and yeast extract as key determinants for enzyme production. Under optimized conditions, the enzyme yield 36.18 IU/mL was obtained. The enzyme was purified by ammonium sulfate fractionation and DEAE–Sepharose chromatography with an overall purification of 5.8-fold. SDS–PAGE revealed a 30&#xa0;kDa subunit, while native-PAGE indicated a homo-tetrameric enzyme with an estimated molecular weight of 120&#xa0;kDa. The purified enzyme displayed optimal activity at pH 9.0 and 30&#xa0;°C. The K<sub><i>m</i></sub> and V<sub><i>max</i></sub> of the enzyme were 14.57 mM and 142.85 µmol/min/mg, respectively. Urate oxidase SA1 showed moderate thermostability, exhibiting half-life of about 2&#xa0;h at 50&#xa0;°C. MALDI–TOF/TOF peptide mapping confirmed identity of enzyme with urate oxidase (P78609.1). In vitro assays using hyperuricemic human serum demonstrated dose-dependent uric acid degradation, reducing levels from 7.50 to 2.73&#xa0;mg/dL within 12&#xa0;h at 1.3 IU/mg, the observed results were found comparable to commercial uricase. These findings suggest that extracellular urate oxidase SA1 may serve as a promising candidate for further development for the management of hyperuricemia and gout.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Extracellular urate oxidase from Arthrobacter creatinolyticus SA1: statistical optimization, purification, and in-vitro evaluation of antihyperuricemic activity

  • 期刊论文

  • 发表日期：

    2026年6月16日

查看全文
  • Shabnam Chaudhary,
  • Kriti Kanwar,
  • Deepika Sharma,
  • Harjodh Singh,
  • Sadanand Pandey,
  • Wamik Azmi

摘要

Urate oxidase (uricase; EC 1.7.3.3) catalyzes the oxidation of uric acid to allantoin, a highly soluble metabolite that is readily excreted. Lack of functional urate oxidase in human’s leads to hyperuricemia, which is associated with gout, tumor lysis syndrome and renal complications. The present study reports statistical optimization, purification, and comprehensive characterization of a novel extracellular urate oxidase secreted by Arthrobacter creatinolyticus SA1. Plackett–Burman Design screening followed by Central Composite Design identified inoculum volume, initial pH, peptone, and yeast extract as key determinants for enzyme production. Under optimized conditions, the enzyme yield 36.18 IU/mL was obtained. The enzyme was purified by ammonium sulfate fractionation and DEAE–Sepharose chromatography with an overall purification of 5.8-fold. SDS–PAGE revealed a 30 kDa subunit, while native-PAGE indicated a homo-tetrameric enzyme with an estimated molecular weight of 120 kDa. The purified enzyme displayed optimal activity at pH 9.0 and 30 °C. The Km and Vmax of the enzyme were 14.57 mM and 142.85 µmol/min/mg, respectively. Urate oxidase SA1 showed moderate thermostability, exhibiting half-life of about 2 h at 50 °C. MALDI–TOF/TOF peptide mapping confirmed identity of enzyme with urate oxidase (P78609.1). In vitro assays using hyperuricemic human serum demonstrated dose-dependent uric acid degradation, reducing levels from 7.50 to 2.73 mg/dL within 12 h at 1.3 IU/mg, the observed results were found comparable to commercial uricase. These findings suggest that extracellular urate oxidase SA1 may serve as a promising candidate for further development for the management of hyperuricemia and gout.